Testing of viscous anti-HIV microbicides using Lactobacillus

Journal of Microbiological Methods

Volumn 88, Issue 2, 2012, Pages 292-296

  Moncla, B J ^a,b   Pryke, K ^b   Rohan, L C ^b,c   Yang, H ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d POPULATION COUNCIL   (United States)

Author keywords

Bacterial quantitation; HIV; Lactobacillus; Microbicide; Vortex mixing

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BOVINE SERUM ALBUMIN; DAPIVIRINE; GLYCEROL; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; PSC RANTES; TENOFOVIR; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS ATROPHAEUS; BACTERIAL SPORE; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG FORMULATION; FILM COATING; HUMAN IMMUNODEFICIENCY VIRUS; LACTOBACILLUS; LACTOBACILLUS JENSENII; NONHUMAN; PRIORITY JOURNAL; SERUM; TOXICITY TESTING; VAGINA FLORA; VISCOSITY; VORTEX MOTION;

ADENINE; ANILIDES; ANIMALS; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CATTLE; CHEMOKINE CCL5; COLONY COUNT, MICROBIAL; EXCIPIENTS; FEMALE; FURANS; HUMANS; LACTOBACILLUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PHOSPHONIC ACIDS; PYRIMIDINES; SERUM ALBUMIN, BOVINE; VAGINA; VISCOSITY;

BACILLUS ATROPHAEUS; BACTERIA (MICROORGANISMS); BOVINAE; LACTOBACILLUS; LACTOBACILLUS JENSENII;

EID: 84862792191     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2011.12.013     Document Type: Article

References (22)

1. Antikainen J., Anton L., Sillanpaa J., Korhonen T.K. Domains in the S-layer protein CbsA of Lactobacillus crispatus involved in adherence to collagens, laminin and lipoteichoic acids and in self- assembly. Mol. Microbiol. 2002, 46:381-394.
2. Antonio M.A., Hawes S.E., Hillier S.L. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J. Infect. Dis. 1999, 180:1950-1956.
3. Anukam K.C., Osazuwa E.O., Ahonkhai I., Reid G. Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin City, Nigeria. Sex. Transm. Dis. 2006, 33:59-62.
4. Baranger K., Zani M.L., Chandenier J., Dallet-Choisy S., Moreau T. The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function. FEBS J. 2008, 275:2008-2020.
5. Claus H., Akca E., Debaerdemaeker T., Evrard C., Declercq J.P., Harris J.R., Schlott B., Konig H. Molecular organization of selected prokaryotic S-layer proteins. Can. J. Microbiol. 2005, 51:731-743.
6. Fontenot J.D., Ball J.M., Miller M.A., David C.M., Montelaro R.C. A survey of potential problems and quality control in peptide synthesis by the fluorenylmethoxycarbonyl procedure. Pept Res. 1991, 4:19-25.
7. Gerhardt P. Diluents and biomass measurement. Manual of methods for general bacteriology 1981, 504-507. American Society for Microbiology, Washington DC. P. Gerhardt (Ed.).
8. Gustafsson R., Ahrne S., Jeppsson B., Benoni C., Olsson C., Stjernquist M., Ohlsson B. The Lactobacillus flora in vagina and rectum of fertile and postmenopausal healthy Swedish women. BMC Womens Health 2011, 11:17.
9. Holmquist L., Kjelleberg S. Changes in viability, respiratory activity and morphology of the marine Vibrio sp. strain S14 during starvation of individual nutrients and subsequent recovery. FEMS Microbiol. Ecol. 1993, 12:215-223.
10. Martin H.L., Richardson B.A., Nyange P.M., Lavreys L., Hillier S.L., Chohan B., Mandaliya K., Ndinya- Achola J.O., Bwayo J., Kreiss J. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 1999, 180:1863-1868.
11. Moncla B.J., Hillier S.L. Why nonoxynol-9 may have failed to prevent acquisition of Neisseria gonorrhoeae in clinical trials. Sex. Transm. Dis. 2005, 32:491-494.
12. Moncla B.J., Pryke K., Isaacs C.E. Killing of Neisseria gonorrhoeae, Streptococcus agalactiae (group B streptococcus), Haemophilus ducreyi, and vaginal Lactobacillus by 3-O-octyl-sn-glycerol. Antimicrob. Agents Chemother. 2008, 52:1577-1579.
13. Patton D.L., Cosgrove Sweeney Y.T., McCarthy T.D., Hillier S.L. Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob. Agents Chemother. 2006, 50:1696-1700.
14. Patton D.L., Sweeney Y.T., Balkus J.E., Rohan L.C., Moncla B.J., Parniak M.A., Hillier S.L. Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations. Antimicrob. Agents Chemother. 2007, 51:1608-1615.
15. Pavlova S.I., Kilic A.O., Kilic S.S., So J.S., Nader-Macias M.E., Simoes J.A., Tao L. Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J. Appl. Microbiol. 2002, 92:451-459.
16. Ranhand J.M. Simple, inexpensive procedure for the disruption of bacteria. Appl. Environ. Microbiol. 1974, 28:66-69.
17. Sadhu K., Domingue P.A.G., Chow A.W., Nelligan J., Bartlett K., Costerton J.W. A morphological study of the in situ tissue-associated autochthonous microflora of the human vagina. Microb. Ecol. Heal. Dis. 1989, 2:99-106.
18. Schwartz J.L., Mauck C., Lai J.J., Creinin M.D., Brache V., Ballagh S.A., Weiner D.H., Hillier S.L., Fichorova R.N., Callahan M. Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study. Contraception 2006, 74:133-140.
19. Seung Won K., Peter C.R., Thomas H.K., Sagar M.G., Ramakrishnan M.A., Senthilvelan A., James E.F. Optimizing the recovery of surrogates for bacterial bioterrorism agents from ventilation filters. CLEAN-Soil, Air, Water 2008, 36:601-608.
20. Simpson A.J., Maxwell A.I., Govan J.R., Haslett C., Sallenave J.M. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 1999, 452:309-313.
21. Tien D., Schnaare R.L., Kang F., Cohl G., McCormick T.J., Moench T.R., Doncel G., Watson K., Buckheit R.W., Lewis M.G., Schwartz J., Douville K., Romano J.W. In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res. Hum. Retroviruses 2005, 21:845-853.
22. Vasquez A., Jakobsson T., Ahrne S., Forsum U., Molin G. Vaginal Lactobacillus flora of healthy Swedish women. J. Clin. Microbiol. 2002, 40:2746-2749.